Distalmotion

Executive Summary

Distalmotion is a Swiss surgical robotics company that has developed the Dexter platform, which has received EU clearance. The company is actively pursuing the US FDA pathway, indicating ambitions for expansion into a significant global market. This regulatory momentum is a crucial strategic angle for an IPO, as it signals a broadening commercialization opportunity and potential for increased adoption of its technology.